FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/034561 [Registered on: 02/07/2021] Trial Registered Prospectively
Last Modified On: 04/07/2021
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   To study the fetomaternal outcome of decreased sodium level in the patients of one of the subtypes of hypertensive disorders in pregnancy and its association with the severity of the disorder  
Scientific Title of Study   To study the correlation of hyponatremia with the fetomaternal outcome in patients of preeclampsia with severe features and to study its association as a marker of the severity of preeclampsia 
Trial Acronym  HOPE 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ramya Lasmi R 
Designation  Junior resident  
Affiliation  Postgraduate Institute of Medical Education and Research  
Address  Room no 10, Department of Obstetrics and Gynecology, PGIMER

Chandigarh
CHANDIGARH
160012
India 
Phone  9442269624  
Fax    
Email  ramyalasmiom26@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Seema Chopra 
Designation  Additional Professor 
Affiliation  Postgraduate Institute of Medical Education and Research  
Address  Room no 10, Department of Obstetrics & Gynaecology,PGIMER

Chandigarh
CHANDIGARH
160012
India 
Phone  7087009351  
Fax    
Email  drseemachopra@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Ramya Lasmi R 
Designation  Junior resident  
Affiliation  Postgraduate Institute of Medical Education and Research  
Address  Room no 10 Department of Obstetrics and gynecology, PGIMER

Chandigarh
CHANDIGARH
160012
India 
Phone  9442269624  
Fax    
Email  ramyalasmiom26@gmail.com  
 
Source of Monetary or Material Support  
PGIMER 
 
Primary Sponsor  
Name  PGIMER 
Address  Sector 12,Chandigarh 160012 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ramya Lasmi R  PGIMER  Department of Obstetrics and gynecology, labour room
Chandigarh
CHANDIGARH 
09442269624

ramyalasmiom26@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PGIMER  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O141||Severe pre-eclampsia,  
 
Intervention / Comparator Agent
Modification(s)  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1)Pregnant women with the period of gestation between 20 to 40 weeks admitted in labour ward with blood pressure more than or equal to 140/90 mmHg measured on 2 occasions 4 hours apart consenting to be enrolled in study.

2)Age more than or equal to 18 years

3)All patients falling under the ACOG Criteria for severe Preeclampsia  
 
ExclusionCriteria 
Details  1)Pregnant women who do not consent for study

2)Women with chronic kidney disease, liver disease, cardiovascular disease, collagen vascular disease, chronic hypertension, diabetes, neoplasm, with major fetal anomaly, endocrine disorders causing electrolyte imbalance, CNS disorders, on steroids /diuretics  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1) Fetomaternal outcome in preeclamptic patients with severe features presenting with hyponatremia
2) Association of hyponatremia with the severity of preeclampsia  
1 year 
 
Secondary Outcome  
Outcome  TimePoints 
Proportion of hyponatremia in preeclamptic patients with severe features   1 YEAR 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/07/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a prospective observational study to study the correlation of hyponatremia with the fetomaternal outcome in preeclamptic patients with severe features and to study whether hyponatremia is an independent marker for the severity of preeclampsia.Sample size is 100.The primary outcome is to study the correlation of hyponatremia with the fetomaternal outcome in preeclamptic patients with severe features and to study association of hyponatremia as an independent marker for the severity of preeclampsia.The secondary outcome is to study the prevalence of hyponatremia in preeclamptic patients with severe features. 
Close